Efficacy and Safety of Aumolertinib as Adjuvant Therapy in Resectable Stage I NSCLC with High-grade Patterns and EGFR Mutations (APPOINT)

被引:0
|
作者
Han, B. [1 ]
Fang, W. [1 ]
Chen, C. [2 ]
Zhang, W. [1 ]
Zhang, B. [1 ]
Yao, F. [1 ]
Shi, J. [1 ]
Yue, D. [3 ]
Qi, Y. [4 ]
Zhu, Z. [5 ]
Xie, J. [6 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Chest Hosp, Shanghai, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Tianjin Med Univ, Canc Inst Hosp, Tianjin, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China
[6] Putian Coll, Affiliated Hosp, Putian, Peoples R China
关键词
aumolertinib; high-grade patterns; NSCLC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.27-09
引用
收藏
页码:S287 / S287
页数:1
相关论文
共 50 条
  • [41] Role of perioperative complications and adjuvant therapy patterns on racial disparity in survival among elderly womenwith high-grade endometrial cancer
    Park, H. K.
    Ruterbusch, J.
    Cote, M. L.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 63 - 63
  • [42] Efficacy and safety of photodynamic therapy mediatied by 5-aminolevulinic acid for the treatment of vaginal high-grade intraepithelial lesions
    Han, Qin
    Wu, Zhangxin
    Guo, Hongyan
    Zhang, Xue
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2022, 39
  • [43] Exploring the efficacy and safety of laser interstitial thermal therapy for recurrent high-grade glioma: the first prospective cohort in China
    Wang, Yihe
    Chen, Sichang
    Shi, Jianwei
    Tang, Ting
    Dai, Yang
    Xu, Jinkun
    Wei, Penghu
    Fan, Xiaotong
    Lu, Jie
    Shan, Yongzhi
    Zhao, Guoguang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [44] Safety and Efficacy of Proton Beam Therapy for High-Grade Glioma: Initial Report From the Proton Collaborative Group (PCG)
    Vora, S. A.
    Gondi, V.
    Tseng, Y. D.
    Vargas, C. E.
    Larson, G. L.
    Tsai, H. K.
    Halasz, L. M.
    Rosen, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E362 - E362
  • [45] Efficacy and Safety of GemcitabineDocetaxel Combination Therapy for Recurrent or Refractory High-grade Osteosarcoma in China: A Retrospective Study of 18 Patients
    Qi, Wei-Xiang
    He, Ai-Na
    Tang, Li-Na
    Shen, Zan
    Lin, Feng
    Yao, Yang
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (05) : 427 - 431
  • [46] PHASE I TRIAL OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY FOLLOWED BY ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH HIGH-GRADE GLIOMAS
    Grimm, Sean
    Marymont, Mary Ann
    Chandler, James
    Muro, Kenji
    Newman, Steven
    Levy, Robert
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2008, 10 (05) : 830 - 830
  • [47] Use of adjuvant therapy and overall survival in stage II low-grade versus high-grade endometrioid endometrial carcinomas: A National Cancer Database study
    Vetter, M. H.
    Bixel, K.
    Felix, A. S.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 256 - 256
  • [48] Locally advanced stage high-grade mucoepidermoid carcinoma of salivary gland in a 9-year-old girl: the controversy of adjuvant therapy
    Micol Martinez, Olga
    Daghoum Dorado, Elena
    Amoros Garcia, Maria Dolores
    Oviedo Ramirez, Maria Isabel
    de la Fuente Munoz, Isabel
    Fuster Soler, Jose Luis
    RARE TUMORS, 2016, 8 (03) : 126 - U51
  • [49] Biomarker testing and adjuvant osimertinib use in patients with resectable EGFR-mutated stage IB-IIIA NSCLC: Physician practices, therapy choice, and barriers among US oncologists
    Aggarwal, Puja
    Savill, Kristin M. Zimmerman
    Jeune-Smith, Yolaine
    Jennings-Zhang, Luke
    Bone, Robert
    Kelly, Ronan Joseph
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis
    Anastasio, Mary Katherine
    Nolin, Angela
    Penvose, Katherine N.
    Lambert, Katherine
    Li, Jessie
    Ledbetter, Leila
    Davidson, Brittany A.
    Havrilesky, Laura J.
    Albright, Benjamin B.
    GYNECOLOGIC ONCOLOGY, 2024, 191 : 10 - 18